Activating ligands of Uncoupling protein 1 identified by rapid membrane protein thermostability shift analysis
Activating ligands of Uncoupling protein 1 identified by rapid membrane protein thermostability shift analysis
复制标题
通过快速膜蛋白热稳定性位移分析鉴定解偶联蛋白 1 的激活配体
DOI:
10.1101/2022.02.03.478984
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Cavalieri R
中科院分区:
文献类型:
--
作者:
Cavalieri R
ObjectiveUncoupling protein 1 (UCP1) catalyses mitochondrial proton leak in brown adipose tissue to facilitate nutrient oxidation for heat production, and may combat metabolic disease if activated in humans. During the adrenergic stimulation of brown adipocytes, free fatty acids generated from lipolysis activate UCP1 via an unclear interaction. Here, we set out to characterise activator binding to purified UCP1 to clarify the activation process, discern novel activators and the potential to target UCP1.MethodsWe assessed ligand binding to purified UCP1 by protein thermostability shift analysis, which unlike many conventional approaches can inform on the binding of hydrophobic ligands to membrane proteins. A detailed activator interaction analysis and screening approach was carried out, supported by investigations of UCP1 activity in liposomes, isolated brown fat mitochondria and UCP1 expression-controlled cell lines.ResultsWe reveal that fatty acids and other activators influence UCP1 through a specific destabilising interaction, behaving as transport substrates that shift the protein to a less stable conformation of a transport cycle. Through the detection of specific stability shifts in screens, we identify novel activators, including the over-the-counter drug ibuprofen, where ligand analysis indicates that UCP1 has a relatively wide structural specificity for interacting molecules. Ibuprofen successfully induced UCP1 activity in liposomes, isolated brown fat mitochondria and UCP1-expressing HEK293 cells but not in cultured brown adipocytes, suggesting drug delivery differs in each cell type.ConclusionsThese findings clarify the nature of the activator-UCP1 interaction and demonstrate that the targeting of UCP1 in cells by approved drugs is in principle achievable as a therapeutic avenue, but requires variants with more effective delivery in brown adipocytes.
登录
查看更多内容
DOI:
--
发表时间:
2020
期刊:
The FEBS Journal
影响因子:
--
作者:
Mathilde S. Piel;S. Masscheleyn;F. Bouillaud;K. Moncoq;B. Miroux
通讯作者:
B. Miroux
影响因子:
29
作者:
Cypess AM;Weiner LS;Roberts-Toler C;Franquet Elía E;Kessler SH;Kahn PA;English J;Chatman K;Trauger SA;Doria A;Kolodny GM
通讯作者:
Kolodny GM
影响因子:
7.7
作者:
Majd H;King MS;Palmer SM;Smith AC;Elbourne LD;Paulsen IT;Sharples D;Henderson PJ;Kunji ER
通讯作者:
Kunji ER
影响因子:
5.7
作者:
Alexandrov, Alexander I.;Mileni, Mauro;Stevens, Raymond C.
通讯作者:
Stevens, Raymond C.
DOI:
--
发表时间:
1990
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Jezek,P;Garlid,KD
通讯作者:
Garlid,KD